Agnieszka Onisko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Agnieszka Onisko has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Marek J. Druzdzel
Faculty of Computer Science, Bialystok University of Technology, Wiejska 45A, Bialystok, 15-351, Poland
2 shared publicationsR. Marshall Austin
Magee-Womens Hospital, Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213
2 shared publications- Allan Tucker
Brunel University London
1 shared publication - Marek J. Druzdzel
Faculty of Computer Science, Białystok University of Technology, Wiejska 45A, 15-351 Białystok, Poland
1 shared publication - R. Marshall Austin
Department of Pathology, Magee-Women's Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
1 shared publication
Latest Publications
- 19 November 2018
- Published by Wiley in Diagnostic Cytopathology
- Vol. 47 (1) , 41-47
Application of Bayesian network modeling to pathology informatics
Background: In the era of extensive data collection, there is a growing need for a large scale data analysis with tools that can handle many variables in one modeling framework. In this article, we present our recent applications of Bayesian network modeling to pathology informatics.Methods: Bayesian networks (BNs) are probabilistic graphical models that represent domain knowledge and allow investigators to process this knowledge following sound rules of probability theory. BNs can be built based on expert opinion as well as learned from accumulating data sets. BN modeling is now recognized as a suitable approach for knowledge representation and reasoning under uncertainty. Over the last two decades BN have been successfully applied to many studies on medical prognosis and diagnosis.Results: Based on data and expert knowledge, we have constructed several BN models to assess patient risk for subsequent specific histopathologic diagnoses and their related prognosis in gynecological cytopathology and breast pathology. These models include the Pittsburgh Cervical Cancer Screening Model assessing risk for histopathologic diagnoses of cervical precancer and cervical cancer, modeling of the significance of benign‐appearing endometrial cells in Pap tests, diagnostic modeling to determine whether adenocarcinoma in tissue specimens is of endometrial or endocervical origin, and models to assess risk for recurrence of invasive breast carcinoma and ductal carcinoma in situ.Conclusions: Bayesian network models can be used as powerful and flexible risk assessment tools on large clinical datasets and can quantitatively identify variables that are of greatest significance in predicting specific histopathologic diagnoses and their related prognosis. Resulting BN models are able to provide individualized quantitative risk assessments and prognostication for specific abnormal findings commonly reported in gynecological cytopathology and breast pathology.
- 19 November 2018
- Published by Wiley in Diagnostic Cytopathology
- Vol. 47 (1) , 41-47
Application of Bayesian network modeling to pathology informatics
Background: In the era of extensive data collection, there is a growing need for a large scale data analysis with tools that can handle many variables in one modeling framework. In this article, we present our recent applications of Bayesian network modeling to pathology informatics.Methods: Bayesian networks (BNs) are probabilistic graphical models that represent domain knowledge and allow investigators to process this knowledge following sound rules of probability theory. BNs can be built based on expert opinion as well as learned from accumulating data sets. BN modeling is now recognized as a suitable approach for knowledge representation and reasoning under uncertainty. Over the last two decades BN have been successfully applied to many studies on medical prognosis and diagnosis.Results: Based on data and expert knowledge, we have constructed several BN models to assess patient risk for subsequent specific histopathologic diagnoses and their related prognosis in gynecological cytopathology and breast pathology. These models include the Pittsburgh Cervical Cancer Screening Model assessing risk for histopathologic diagnoses of cervical precancer and cervical cancer, modeling of the significance of benign‐appearing endometrial cells in Pap tests, diagnostic modeling to determine whether adenocarcinoma in tissue specimens is of endometrial or endocervical origin, and models to assess risk for recurrence of invasive breast carcinoma and ductal carcinoma in situ.Conclusions: Bayesian network models can be used as powerful and flexible risk assessment tools on large clinical datasets and can quantitatively identify variables that are of greatest significance in predicting specific histopathologic diagnoses and their related prognosis. Resulting BN models are able to provide individualized quantitative risk assessments and prognostication for specific abnormal findings commonly reported in gynecological cytopathology and breast pathology.
- Open Access
- 1 January 2016
- Published by Elsevier in Journal of Pathology Informatics
- Vol. 7 (1) , 50
How to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modeling
- 1 January 2016
- Published by Elsevier in Journal of Pathology Informatics
- Vol. 7 (1) , 50
Open AccessHow to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modeling
- 1 January 2015
- Published by Springer Nature
- p. 207-218
Dynamic Bayesian Network for Cervical Cancer Screening
- 1 January 2015
- Published by Springer Nature
- p. 207-218
Dynamic Bayesian Network for Cervical Cancer Screening
- 1 January 2015
- Published by Springer Nature
- p. 181-188
Prediction and Prognosis of Health and Disease